Urban Fritsche
Urban Fritsche is a pharmaceutical analyst at Zürcher Kantonalbank, specializing in the evaluation of biotech and pharmaceutical companies. He provides insights into market dynamics and the potential impacts of drug development on stock performance. In recent news, he commented on the implications of a possible merger between AstraZeneca and Bristol Myers Squibb, highlighting that such a deal could lead to increased competition and market shifts.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Urban Fritsche, a pharmaceutical analyst, discussed the potential advantages for competitors like Roche and Novartis if the merger occurs.
5